Ledger.Open graph →
SEC Form D · filed January 8, 2014

Bell Biosystems, Inc

Offering
$3.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Stuart B. Berman · San Francisco, CADirectorChristian B. Olgaard · San Francisco, CADirectorBell, Iii B. Caleb · San Francisco, CAExec · DirectorDaniel B. Bell · San Francisco, CAExec · DirectorMichael Logsdon · Plano, TXDirectorDonna Pawl · Acworth, GAExec · DirectorLynn C. Greene · Larkspur, COExec · DirectorPaul C. Marcussen · New York, NYDirectorJason C. Alderman · New York, NYDirectorGeorge, Jr. F. Hamel · San Francisco, CAExec · DirectorBrandi Scott · Plano, TXDirectorCynthia Basham · Acworth, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗